Stocks and Investing Stocks and Investing
Thu, December 5, 2024
[ Thu, Dec 05th 2024 ] - Think Advisor
Morningstar's Rekenthaler Retires; Praises 'Miracle' of Stocks
[ Thu, Dec 05th 2024 ] - MSN
Dow Jones Touches 45,000 Amid Trump Rally: ETFs to Bet On
[ Thu, Dec 05th 2024 ] - MSN
Concerned about ASX shares at all-time highs? Don't worry, you've got options
[ Thu, Dec 05th 2024 ] - MSN
Here's Why Walt Disney (DIS) is a Strong Growth Stock
[ Thu, Dec 05th 2024 ] - The Motley Fool
Why SoundHound AI Stock Skyrocketed 85% in November
[ Thu, Dec 05th 2024 ] - Seeking Alpha
BNY Mellon Global Equity Income Fund Q3 2024 Commentary
[ Thu, Dec 05th 2024 ] - Kiplinger
Is Coinbase Stock a Buy or Hold as Bitcoin Tops $100,000?
[ Thu, Dec 05th 2024 ] - MSN
Retirees: The Only 3 ETFs You Need to Own for Passive Income and Growth in Your Golden Years
[ Thu, Dec 05th 2024 ] - MSN
Intel's Stock Just Did Something It Hasn't Done Since 2022
[ Thu, Dec 05th 2024 ] - The Globe and Mail
What Nvidia Stock Investors Should Know About Met .. Latest Artificial Intelligence (AI) Announcement
[ Thu, Dec 05th 2024 ] - MSN
U.S. stock market rally to continue in final weeks of 2024, Goldman strategist says
[ Thu, Dec 05th 2024 ] - MSN
Brokers Suggest Investing in Abbott (ABT): Read This Before Placing a Bet
[ Thu, Dec 05th 2024 ] - MSN
VOO ETF Update, 12/5/2024
[ Thu, Dec 05th 2024 ] - The Motley Fool
Why Vistra Stock Jumped 28% in November
[ Thu, Dec 05th 2024 ] - MSN
Here Is Why Bargain Hunters Would Love Fast-paced Mover FlexShopper (FPAY)
[ Thu, Dec 05th 2024 ] - The Motley Fool UK
Rolls-Royce shares just did this for the first time ever!
[ Thu, Dec 05th 2024 ] - Investing
What is the 2025 economic outlook in a new leadership and policy era
[ Thu, Dec 05th 2024 ] - MSN
Here's Why Warren Buffett and Berkshire Hathaway .. Investing Strategy With Donald Trump as President
[ Thu, Dec 05th 2024 ] - Seeking Alpha
Sabesp Q3: Good Result, But Macro Scenario Continues To Leave Me Skeptical
[ Thu, Dec 05th 2024 ] - cnbctv18
SEBI suggests call auction session for stock closing prices, replacing VWAP
[ Thu, Dec 05th 2024 ] - Wall Street Journal
Market Timing Has Picked Up Since Covid. It Has Cost Investors Dearly.
[ Thu, Dec 05th 2024 ] - Thomas Matters
SEBI considers implementing auction session at ma .. ose to minimise tracking errors for passive funds
[ Thu, Dec 05th 2024 ] - Thomas Matters
Harbor Mid Cap Value Fund Q3 2024 Commentary
[ Thu, Dec 05th 2024 ] - Thomas Matters
Dow Jones Futures: Bitcoin Tops $100,000 Amid Powell Comments; Nvidia Ready To Run?
[ Thu, Dec 05th 2024 ] - Thomas Matters
Harbor Large Cap Value Fund Q3 2024 Commentary
[ Thu, Dec 05th 2024 ] - Thomas Matters
Nvidia Stock Is Up 187% in 2024, but Here's Anoth .. or Stock to Buy in 2025, According to Wall Street
[ Thu, Dec 05th 2024 ] - Thomas Matters
Five Below stock surges on raised guidance, new CEO
[ Thu, Dec 05th 2024 ] - Thomas Matters
Should You Invest in the SPDR S&P Aerospace & Defense ETF (XAR)?
[ Thu, Dec 05th 2024 ] - Thomas Matters
Schroders financial advisers predict cash savings exodus
[ Thu, Dec 05th 2024 ] - Thomas Matters
Should You Forget Pfizer and Buy These Unstoppable Stocks Instead?

Should You Forget Pfizer and Buy These Unstoppable Stocks Instead?


Published on 2024-12-05 08:01:19 - Thomas Matters, WOPRAI
  Print publication without navigation

  • The company is still suffering from the significant drop in sales of its coronavirus products and the less-than-impressive financial results it has produced during the past two years. And although Pfizer's revenue is growing again,

The article from MSN Money discusses whether investors should consider moving away from Pfizer, a well-known pharmaceutical company, towards other "unstoppable" stocks. It highlights the challenges Pfizer faces, including patent expirations and competition from generic drugs, which could impact its future growth. Instead, the article suggests looking into stocks like Novo Nordisk, known for its advancements in diabetes care and obesity treatments, and Eli Lilly, which has shown strong performance with its diabetes and Alzheimer's drugs. Additionally, Vertex Pharmaceuticals is mentioned for its monopoly in cystic fibrosis treatments and potential in other genetic diseases. The piece argues that these companies might offer better growth prospects due to their innovative pipelines and market positions, potentially making them more attractive investments compared to Pfizer in the current market environment.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/money/top-stocks/should-you-forget-pfizer-and-buy-these-unstoppable-stocks-instead/ar-AA1vk5nQ ]
Contributing Sources